Clinical Trial Update: Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating simtuzumab in adults with liver fibrosis and hepatitis C, including HIV co-infection; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Simtuzumab (simtuzumab)

Snippet

Sponsor: Gilead Sciences | Conditions: Liver Fibrosis, Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2019-10-09